The inHealth Precision Medicine Conference

Immunotherapy: Precision Medicine in Action The importance of keeping the promise and potential of immunotherapy alive

The first cancer immunotherapy was approved in 2011; today, there are more than 70 such drugs in the clinical pipeline. By 2020, the cancer treatment industry is expected to achieve $16.55 billion dollars in revenue. Read our policy brief to learn more about milestones in cancer immunotherapy.

What do precision medicine, Johns Hopkins inHealth and Darwin have in common? If you’re interested, please plan to attend our first ever inHealth Precision Medicine Conference on Tuesday, March 27 from 8am to 1pm in Turner Auditorium. You’ll learn about the new analytics, big data, and measurement platforms we’re building to transform medicine, as well as some highly creative approaches your colleagues have taken to further define individual diseases and conditions to both improve care and minimize cost.

March 27, 2018, Turner Auditorium

Goal: Framing the transformation of health care at Johns Hopkins

7:00 a.m. – 8:00 a.m. Breakfast and registration

8:00 a.m. – 8:30 a.m. Keynote Speaker – A. Rosen: Hopkins inHealth: Recognizing Wonder at Scale

Session I – Precision Medicine: Template for the future of Johns Hopkins Medicine

8:30 a.m. – 9:00 a.m. – Precision Medicine Analytics Platform: Dwight Raum

9:00 a.m. – 9:15 a.m. – APL's Health Mission: Collaborations with JHM: Alan Ravitz

9:15 a.m. – 9:30 a.m. – Applications of Data Science to Precision Medicine: Corban Rivera

9:30 a.m. – 9:45 a.m. –  Transforming Data Delivery with the Precision Medicine Platform: Diana Gumas

9:45 a.m. – 10:00 a.m. – Released Tumor DNA as a Clinical Biomarker Ken Kinzler

10:00 a.m. – 10:15 a.m. – Imaging Neurodegeneration Using Retinal Optical Coherence Tomography Peter A. Calabresi

10:15 a.m. – 10:45 a.m. – Break

Session II – Creative subsetting: Voyages of the Hopkins “Beagle”

10:45 a.m. – 11:00 a.m. – H. Ballentine Carter: A prostate cancer subgroup: Individualizing care and informing health policy

11:00 a.m. – 11:15 a.m. – Peter Searson: Patient mobility and the importance of high information content data

11:15 a.m. – 11:30 a.m. – Joshua Betz: Optimizing Clinical Trial Designs for Evaluating Subgroup Effects

11:30 a.m. – 11:45 a.m. – Natalia Trayanova: Predictive Computational Modeling in Diagnosis and Treatment of Heart Rhythm Disorders

11:45 a.m. – 12:00 p.m. – David McConkey: Genomic subtypes in the clinical management of bladder cancer

12:00 p.m. – 1:00 p.m. – Roundtable on the Precision Medicine Path to Value

Moderator: Antony Rosen

Roundtable participants: Redonda Miller, Patty Brown, Stephanie Reel, Landon King, Robert Kasdin

1:00 p.m. – Lunch